Furthermore, bioinformatics analyses of human lung adenocarcinoma samples indicated that poorly differentiated tumors express significantly lower levels of RIPK4, which was associated with poorer overall survival. The gene discussed is RIPK4; the disease is lung adenocarcinoma.